Age-related effects on thymic output and homeostatic T cell expansion following depletional induction in renal transplant recipients
Open Access
- 20 May 2021
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (9) , 3163-3174
Abstract
No abstract availableKeywords
Funding Information
- Roche Organ Transplant Research Foundation (346678023)
- National Institutes of Health (AI097423)
This publication has 30 references indexed in Scilit:
- Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-upAmerican Journal of Transplantation, 2020
- Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant RecipientsAmerican Journal of Transplantation, 2015
- Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin InhibitorsAmerican Journal of Transplantation, 2014
- B Cell Repopulation After Alemtuzumab Induction—Transient Increase in Transitional B Cells and Long-Term Dominance of Naïve B CellsAmerican Journal of Transplantation, 2012
- Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant RecipientsAmerican Journal of Transplantation, 2011
- Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant RecipientsAmerican Journal of Transplantation, 2010
- Calcineurin Inhibitor Withdrawal After Renal Transplantation with Alemtuzumab: Clinical Outcomes and Effect on T-Regulatory CellsAmerican Journal of Transplantation, 2008
- RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)Transplantation, 2003
- Campath-1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot StudyAmerican Journal of Transplantation, 2003
- Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapyThe Lancet, 2002